Cargando…
Do Genomic Factors Play a Role in Diabetic Retinopathy?
Although there is strong clinical evidence that the control of blood glucose, blood pressure, and lipid level can prevent and slow down the progression of diabetic retinopathy (DR) as shown by landmark clinical trials, it has been shown that these factors only account for 10% of the risk for develop...
Autores principales: | Cabrera, Andrea P., Monickaraj, Finny, Rangasamy, Sampathkumar, Hobbs, Sam, McGuire, Paul, Das, Arup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019561/ https://www.ncbi.nlm.nih.gov/pubmed/31947513 http://dx.doi.org/10.3390/jcm9010216 |
Ejemplares similares
-
Chemokine Mediated Monocyte Trafficking into the Retina: Role of Inflammation in Alteration of the Blood-Retinal Barrier in Diabetic Retinopathy
por: Rangasamy, Sampathkumar, et al.
Publicado: (2014) -
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
por: Das, Arup, et al.
Publicado: (2016) -
Genotypes and Phenotypes: A Search for Influential Genes in Diabetic Retinopathy
por: Cabrera, Andrea P., et al.
Publicado: (2020) -
Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets
por: Rangasamy, Sampathkumar, et al.
Publicado: (2012) -
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review
por: Milluzzo, Agostino, et al.
Publicado: (2022)